ZBTB18 and metabolic dysfunction-associated steatotic liver disease: Consistently, we also found the reduction of hepatic Zbtb18 expression in several NAFLD mice models, including db/db diabetic mice, ob/ob obese mice, and HFD-induced obese mice (Fig. 1c–e).